Kazushi Kishi

Dr. Kazushi Kishi

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2001 in Radiology
Verified
Journal Article
Closed access
MNMotoki Nakai
Motoki Nakai
MSMorio Sato
Morio Sato
NKNobuyuki Kawai
Nobuyuki Kawai
HMHiroki Minamiguchi
Hiroki Minamiguchi
MMMitsunori Masuda
Mitsunori Masuda
KKKazushi Kishi
Kazushi Kishi
To investigate factors related to the development of internal mammary arteries (IMAs) as feeding arteries of hepatocellular carcinomas (HCCs). In 30 patients with HCC located in ventral hepatic areas directly beneath the diaphragm, bilateral internal mammary arteriography was performed to explore involvement of the IMA with HCC. The number of previous transcatheter arterial embolizations (TAEs), tumor size, time from initial TAE to IMA angiography, inferior phrenic artery (IPA) involvement with tumor, presence of hepatic artery occlusion, and use of other treatments were compared in groups with and without involvement of the IMA. The group with IMA involvement included 10 patients; the group without involvement, 20 patients. TAE had been performed two to 12 times in the group with involvement and zero to six times in the group without involvement (P =.01). Mean tumor sizes in these two groups were 5.1 and 6.0 cm, respectively; hepatic artery occlusion was noted in nine and zero patients (P =.01) in the two groups. The time from initial TAE to IMA angiography ranged from 3 to 53 months (median, 31.5 months) and from zero to 89 months (median, 0 months) (P =.01). IPA involvement was observed in seven and four patients (P =.015). These results strongly suggest that, regardless of tumor size, when HCCs are located in the ventral hepatic areas directly beneath the diaphragm, the IMAs serve as feeding arteries in patients with hepatic artery occlusion caused by repeated TAE.

1 October 2009 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
KKKazushi Kishi
Kazushi Kishi
TSTetsuo Sonomura
Tetsuo Sonomura
SSShintaro Shirai
Shintaro Shirai
MSMorio Sato
Morio Sato
KTKayo Tanaka
Kayo Tanaka

10 June 2011 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
KKKazushi Kishi
Kazushi Kishi
HMHiroki Maeda
Hiroki Maeda
YNYasushi Nakamura
Yasushi Nakamura
SSShintaro Shirai
Shintaro Shirai
MSMorio Sato
Morio Sato

1 January 1994 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
KKKazushi Kishi
Kazushi Kishi
HKHisashi Kobayashi
Hisashi Kobayashi
TSTadatoshi Suruda
Tadatoshi Suruda
MOMasahiro Ohata
Masahiro Ohata
TSTetsuo Sonomura
Tetsuo Sonomura
RYRyusaku Yamada
Ryusaku Yamada

1 March 2012 in Brachytherapy
Verified
Journal Article
Closed access
KKKazushi Kishi
Kazushi Kishi
MSMorio Sato
Morio Sato
SSShintaro Shirai
Shintaro Shirai
TSTetsuo Sonomura
Tetsuo Sonomura
RYRyuichi Yamama
Ryuichi Yamama

15 June 2012 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
KKKazushi Kishi
Kazushi Kishi
YMYasushi Mabuchi
Yasushi Mabuchi
TSTetsuo Sonomura
Tetsuo Sonomura
SSShintaro Shirai
Shintaro Shirai
YNYasutaka Noda
Yasutaka Noda
KIKazuhiko Ino
Kazuhiko Ino
The purpose of this study is to develop a procedure for eradicative brachytherapy that can deliver a curative boost dose to bulky (>4 cm) vaginal stump recurrence of uterine cancer without risk of damaging surrounding organs. We separated risk organs (the rectum and sigmoid) from the target during brachytherapy, with a hyaluronate gel injection into the pararectal space via the percutaneous paraperineal approach under local anesthesia. The rectum anchored to the sacrum by native ligament was expected to shift posteriorly. We encountered a patient with bulky stump recurrence of uterine cancer, approximately 8 cm in maximum diameter. She was complaining of abdominal pain and constipation due to bowel encasement. Following 50 Gy of external beam radiotherapy, we applied a single fraction of brachytherapy under gel separation and delivered 14.5 Gy (50.8 GyE: equivalent dose in 2-Gy fraction calculated with linear quadratic model at α/β = 3) to the target. The gel injection procedure was completed in 30 min without complications. A total irradiation dose of 100.8 GyE was delivered to the target and the cumulative minimum dose to the most irradiated rectosigmoidal volume of 2 cc (cumulative D2cc) was calculated as 58.5 GyE with gel injection, and was estimated to be 96 GyE without. Over three years, the local stump tumor has completely disappeared, with no complications. Brachytherapy with a pararectal gel injection can be a safe and effective eradicative option for bulky vaginal stump recurrence.